Nanalysis Scientific Corp.
NSCIF
$0.2215
$0.01175.58%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 31.62M | 29.11M | 25.91M | 21.08M | 19.19M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.62M | 29.11M | 25.91M | 21.08M | 19.19M |
| Cost of Revenue | 24.06M | 22.60M | 21.18M | 18.14M | 16.62M |
| Gross Profit | 7.55M | 6.52M | 4.72M | 2.94M | 2.57M |
| SG&A Expenses | 8.36M | 8.54M | 8.74M | 9.20M | 10.11M |
| Depreciation & Amortization | 3.18M | 3.17M | 3.23M | 3.27M | 3.41M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.88M | 34.65M | 33.52M | 31.12M | 30.85M |
| Operating Income | -4.26M | -5.54M | -7.61M | -10.03M | -11.66M |
| Income Before Tax | -5.37M | -8.94M | -10.73M | -12.47M | -14.58M |
| Income Tax Expenses | 725.50K | 633.10K | 405.20K | -14.70K | -1.25M |
| Earnings from Continuing Operations | -6.09 | -9.58 | -11.14 | -12.46 | -13.32 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00 | 0.00 | 166.00K | 435.90K | 732.10K |
| Net Income | -6.09M | -9.58M | -10.97M | -12.02M | -12.59M |
| EBIT | -4.26M | -5.54M | -7.61M | -10.03M | -11.66M |
| EBITDA | -3.63M | -4.25M | -5.61M | -7.32M | -8.75M |
| EPS Basic | -0.06 | -0.09 | -0.11 | -0.12 | -0.13 |
| Normalized Basic EPS | -0.03 | -0.04 | -0.05 | -0.06 | -0.07 |
| EPS Diluted | -0.06 | -0.09 | -0.11 | -0.12 | -0.13 |
| Normalized Diluted EPS | -0.03 | -0.04 | -0.05 | -0.06 | -0.07 |
| Average Basic Shares Outstanding | 430.88M | 419.21M | 405.38M | 396.63M | 389.40M |
| Average Diluted Shares Outstanding | 430.88M | 419.21M | 405.38M | 396.63M | 389.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |